Russell John Tait
Gründer bei PolyActiva Pty Ltd.
Profil
Russell John Tait has founded PolyActiva Pty Ltd.
in 2010, where he currently holds the position of Chief Executive Officer & Director.
Dr. Tait's former jobs include Director-Business Development at Commonwealth Scientific & Industrial Research Organisation, Product Development Pharmacist at GlaxoSmithKline Investments Pty Ltd., and Manager-Product Feasibility at F.H.
Faulding Pty Ltd.
Dr. Tait's education history includes an undergraduate degree from the University of Melbourne.
Aktive Positionen von Russell John Tait
Unternehmen | Position | Beginn |
---|---|---|
PolyActiva Pty Ltd.
PolyActiva Pty Ltd. BiotechnologyHealth Technology PolyActiva Pty Ltd. develops drug-polymer conjugate technology. Its platform technology is used to make plastic components for medical devices from drugs and manufacture process is novel and provides greater flexibility over the composition of the final material and better product outcomes compared with competitor technologies. The firm has built drug-polymer conjugates from a number of drug candidates with different chemical structures and linkage points, demonstrating the plasticity of the technology and developed a number of functional co-monomers and polymer segments, which modularises the production of the final conjugate. The company was founded in February 2010 and is headquartered in Melbourne, Australia. | Gründer | 01.02.2010 |
Ehemalige bekannte Positionen von Russell John Tait
Unternehmen | Position | Ende |
---|---|---|
F.H. Faulding Pty Ltd. | Corporate Officer/Principal | - |
Commonwealth Scientific & Industrial Research Organisation
Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia. | Corporate Officer/Principal | - |
Glaxosmithkline Investments Pty Ltd.
Glaxosmithkline Investments Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Investments Pty Ltd. is an Australian company. | Corporate Officer/Principal | - |
Ausbildung von Russell John Tait
University of Melbourne | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Commonwealth Scientific & Industrial Research Organisation
Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia. | Commercial Services |
Glaxosmithkline Investments Pty Ltd.
Glaxosmithkline Investments Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Investments Pty Ltd. is an Australian company. | Health Technology |
F.H. Faulding Pty Ltd. | |
PolyActiva Pty Ltd.
PolyActiva Pty Ltd. BiotechnologyHealth Technology PolyActiva Pty Ltd. develops drug-polymer conjugate technology. Its platform technology is used to make plastic components for medical devices from drugs and manufacture process is novel and provides greater flexibility over the composition of the final material and better product outcomes compared with competitor technologies. The firm has built drug-polymer conjugates from a number of drug candidates with different chemical structures and linkage points, demonstrating the plasticity of the technology and developed a number of functional co-monomers and polymer segments, which modularises the production of the final conjugate. The company was founded in February 2010 and is headquartered in Melbourne, Australia. | Health Technology |